HOME >> BIOLOGY >> NEWS
Presentation of the first The Dr. Paul Janssen Award For Biomedical Research

Johnson & Johnson is pleased to invite you to Janssen Pharmaceutica for the presentation of the first The Dr. Paul Janssen Award for Biomedical Research. An international selection committee of prominent medical personalities including Sir Richard Sykes, Dr. Solomon Snyder, Dr. Edward Scolnick and Nobel Prize winners Dr. Arvid Carlsson, Dr. Jean-Marie Lehn and Dr. Harmut Michel, have spent the past year searching for a researcher whose work has made a groundbreaking contribution to medical progress.

On September 12, 2006, Mrs. Dora Janssen will present The Dr Paul Janssen Award for Biomedical Research to the inaugural winner at a scientific symposium and press conference in Beerse, Belgium. The winner's research is considered by many to be one of the biggest medical breakthroughs in recent years.

The press conference will be followed by a symposium where the winner's research subject will be discussed in more detail. On that same evening, there will be an award presentation ceremony. We would like to invite you to both events, and we would be pleased if you were able to attend. Details are enclosed.

For Johnson & Johnson, biomedical research is very important. The Dr. Paul Janssen Award for Biomedical Research is intended, in particular, to stimulate active researchers to reach new heights with their scientific work, just as Dr. Janssen, or "Dr. Paul" as he was known to many of his colleagues, had so often with his research.

September 12th also commemorates Dr. Paul's 80th birthday. Throughout the world, he is regarded as one of the most important pharmaceutical researchers and innovators. But outside the medical world, too, his work is highly valued, as was evidenced by his second place in the referendum that was held last year for the Greatest Belgian of All Time.

For more information on the Award, please go to www.pauljanssenaward.com

PROGRAM

10.45 a.m. Welcome and Coffee

11.00 a.m.
'"/>

Contact: Sarah De Potter
sdepotter@trimedia.be
32-027-130-718
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
5-Sep-2006


Page: 1 2

Related biology news :

1. Eureka! Presentation to the European Parliament
2. Saudi Arabias KAUST names WHOI first research partner
3. Which came first, the moth or the cactus?
4. In a first, Einstein scientists discover the dynamics of transcription in living mammalian cells
5. Seawater intrusion is the first cause of contamination of coastal aquifers
6. Camera-shy deer caught for first time
7. CTRC enrolls first patients in novel phase II study for sarcoma -- living virus destroys cancer cell
8. New joint replacement material developed at MGH put to first clinical use
9. Liverpool amongst first in UK to install unique DNA sequencing technology
10. A first-principles model of early evolution
11. Worlds first X-ray free electron laser is on course to completion

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/21/2020)... ... August 19, 2020 , ... “How can we help?”, asks ... Salivary Bioscience for more than twenty years. Together with Douglas Granger, Ph.D., founder ... Bioscience: Foundations of Interdisciplinary Saliva Research and Applications ," and Steven Granger, Ph.D., ...
(Date:8/12/2020)... ... August 11, 2020 , ... Both Roche, based in ... into license agreements with Housey Pharma’s HMI subsidiary to gain access to its ... annual Research and Development spending in excess of US $10 billion. , Scientists ...
(Date:8/7/2020)... , ... August 06, 2020 , ... ... participate in the prestigious National STEM Scholar Program, a unique professional development program ... and project support for middle school science teachers nationwide. , Created in partnership ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is now offering patients ... million stem cells total, patients may choose which extremities they would like treated. , ... (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is obtained from a ...
(Date:7/31/2020)... ... ... eSource has long been touted as the solution to high data management and monitoring ... did not take off as quickly as people initially expected, and where eSource is ... data electronically for clinical trials and then repurposing it for downstream analysis, at a ...
(Date:7/18/2020)... ... July 16, 2020 , ... “We are thrilled to deliver this new ... only technology of its kind on the market and we were pleased that the ... capacity of traditional cultured ingredients, creating a natural way to extend the shelf life ...
(Date:7/10/2020)... HONG KONG (PRWEB) , ... July 09, 2020 ... ... chemical compound called 1-phenyl-2-thiourea (PTU) is commonly used to suppress pigment formation in ... years, the PolyU research team led by Dr MA has been using the ...
Breaking Biology Technology:
Cached News: